Skip to main content
. 2013 Jan 7;11:6. doi: 10.1186/1479-5876-11-6

Table 4.

Univariate and multivariate analyses of stage I/II disease-free survival and stage III/IV overall survival

 
Univariate Analysis
Multivariate Analysis
Univariate Analysis
Multivariate Analysis
Clinical Factors Recurrences/No. of Patients (stage I/II) Log-Rank P Risk Ratio (95%CI) Wald P Deaths/No. of Patients (stage III/IV) Log-Rank P Risk Ratio (95%CI) Wald P
Sex
 
0.314
1.0
NS
 
0.337
1.0
NS
Female
9/37
 
 
 
42/71
 
 
 
Male
9/54
 
 
 
43/64
 
 
 
Age, years
0.999
1.0
NS
 
<0.001
3.753
<0.001
<70
13/65
 
 
 
58/99
 
(1.746-8.070)
 
≥70
5/26
 
 
 
27/36
 
 
 
TNM stage
0.222
1.0
NS
 
0.084
1.0
NS
p I
0/8
 
 
 
 
 
 
 
p II
18/83
 
 
 
 
 
 
 
p III
 
 
 
 
82/127
 
 
 
p IV
 
 
 
 
3/8
 
 
 
Tumor invasion
0.408
1.0
NS
 
0.842
1.0
NS
pT1
0/1
 
 
 
 
 
 
 
pT2
0/7
 
 
 
3/4
 
 
 
pT3
18/77
 
 
 
79/125
 
 
 
pT4
0/6
 
 
 
3/6
 
 
 
Lymph node NO. /metastasis
0.006
1.0
NS
 
<.001
4.450
<.001
0-7/pN0
9/25
 
 
 
2/8
 
(2.675-7.401)
 
8–12/pN1
4/48
 
 
 
65/105
 
 
 
>12/pN2
5/18
 
 
 
18/22
 
 
 
Grade
 
0.329
1.0
NS
 
0.132
1.0
NS
Well
6/28
 
 
 
18/29
 
 
 
Moderate
8/50
 
 
 
55/90
 
 
 
Poor
4/13
 
 
 
12/16
 
 
 
Tumor size, cm
0.049
1.0
0.099
 
0.249
1.0
NS
<2
2/20
 
 
 
25/37
 
 
 
2-5
12/63
 
 
 
42/72
 
 
 
>5
4/8
 
 
 
18/26
 
 
 
Location
0.164
1.0
NS
 
 
0.440
1.0
NS
Colon
11/40
 
 
 
44/75
 
 
 
Rectum
7/51
 
 
 
41/60
 
 
 
CXCL14
 
0.018
2.92 (1.15-7.40)
0.024
 
0.003
3.087 (1.866-5.107)
<0.001
Low
10/69
 
 
 
39/68
 
 
 
High 8/22       46/67      

Abbreviation: NS, not significant.